Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer

Clinical trial NCT00115635 · COMPLETED

Trial details

NCT number: NCT00115635
Sponsor: Herlev Hospital
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2005-03-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.